A Computational Model for Predicting Nanoparticle Accumulation in Tumor Vasculature

Frieboes, Hermann B.; Wu, Min; Lowengrub, John; Decuzzi, Paolo; Cristini, Vittorio
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Vascular targeting of malignant tissues with systemically injected nanoparticles (NPs) holds promise in molecular imaging and anti-angiogenic therapies. Here, a computational model is presented to predict the development of tumor neovasculature over time and the specific, vascular accumulation of blood-borne NPs. A multidimensional tumor-growth model is integrated with a mesoscale formulation for the NP adhesion to blood vessel walls. The fraction of injected NPs depositing within the diseased vasculature and their spatial distribution is computed as a function of tumor stage, from 0 to day 24 post-tumor inception. As the malignant mass grows in size, average blood flow and shear rates increase within the tumor neovasculature, reaching values comparable with those measured in healthy, pre-existing vessels already at 10 days. The NP vascular affinity, interpreted as the likelihood for a blood-borne NP to firmly adhere to the vessel walls, is a fundamental parameter in this analysis and depends on NP size and ligand density, and vascular receptor expression. For high vascular affinities, NPs tend to accumulate mostly at the inlet tumor vessels leaving the inner and outer vasculature depleted of NPs. For low vascular affinities, NPs distribute quite uniformly intra-tumorally but exhibit low accumulation doses. It is shown that an optimal vascular affinity can be identified providing the proper balance between accumulation dose and uniform spatial distribution of the NPs. This balance depends on the stage of tumor development (vascularity and endothelial receptor expression) and the NP properties (size, ligand density and ligand-receptor molecular affinity). Also, it is demonstrated that for insufficiently developed vascular networks, NPs are transported preferentially through the healthy, pre-existing vessels, thus bypassing the tumor mass. The computational tool described here can effectively select an optimal NP formulation presenting high accumulation doses and uniform spatial intra-tumor distributions as a function of the development stage of the malignancy.


Related Articles

  • TEM8 Targeted Cancer Therapy. Frankel, Arthur E.; Carter, Carol; Kuo, Shu-Ru; Woo, Jung-Hee; Mauldin, Jeremy; Liu, Jen-Sing // Anti-Cancer Agents in Medicinal Chemistry;2011, Vol. 11 Issue 10, p983 

    Tumor growth depends upon access to host blood vessels. Many steps in tumor angiogenesis have been defined including tumor cell hypoxia, tumor cell secretion of pro-angiogenic growth factors, receptor activation on host endothelium and stroma, and establishment of new blood vessels feeding the...

  • A constrained mixture model for developing mouse aorta. Wagenseil, Jessica // Biomechanics & Modeling in Mechanobiology;Oct2011, Vol. 10 Issue 5, p671 

    Mechanical stresses influence the structure and function of adult and developing blood vessels. When these stresses are perturbed, the vessel wall remodels to return the stresses to homeostatic levels. Constrained mixture models have been used to predict remodeling of adult vessels in response...

  • The Extracellular Matrix of Blood Vessels. Eble, Johannes A.; Niland, Stephan // Current Pharmaceutical Design;4/21/2009, Vol. 15 Issue 12, p1385 

    Blood vessels are highly organized and complex structure, which are far more than simple tubes conducting the blood to almost any tissue of the body. They are able to autonomously regulate the blood flow, thus providing the tissues an optimal support of oxygen and nutrients and an efficient...

  • Physical determinants of vascular network remodeling during tumor growth. Welter, M.; Rieger, H. // European Physical Journal E -- Soft Matter;Oct2010, Vol. 33 Issue 2, p149 

    The process in which a growing tumor transforms a hierarchically organized arterio-venous blood vessel network into a tumor specific vasculature is analyzed with a theoretical model. The physical determinants of this remodeling involve the morphological and hydrodynamic properties of the initial...

  • Efficient discovery of bioactive scaffolds by activity-directed synthesis. Karageorgis, George; Warriner, Stuart; Nelson, Adam // Nature Chemistry;Oct2014, Vol. 6 Issue 10, p872 

    The structures and biological activities of natural products have often provided inspiration in drug discovery. The functional benefits of natural products to the host organism steers the evolution of their biosynthetic pathways. Here, we describe a discovery approach-which we term...

  • Periodicity in tumor vasculature targeting kinetics of ligand-functionalized nanoparticles studied by dynamic contrast enhanced magnetic resonance imaging and intravital microscopy. Hak, Sjoerd; Cebulla, Jana; Huuse, Else; Davies, Catharina de; Mulder, Willem; Larsson, Henrik; Haraldseth, Olav // Angiogenesis;Jan2014, Vol. 17 Issue 1, p93 

    In the past two decades advances in the development of targeted nanoparticles have facilitated their application as molecular imaging agents and targeted drug delivery vehicles. Nanoparticle-enhanced molecular imaging of the angiogenic tumor vasculature has been of particular interest. Not only...

  • Tumor-associated endothelial cells display GSTP1 and RARβ2 promoter methylation in human prostate cancer. Grover, Amelia C.; Tangrea, Michael A.; Woodson, Karen G.; Wallis, Benjamin S.; Hanson, Jeffrey C.; Chuaqui, Rodrigo F.; Gillespie, John W.; Erickson, Heidi S.; Bonner, Robert F.; Pohida, Thomas J.; Emmert-Buck, Michael R.; Libutti, Steven K. // Journal of Translational Medicine;2006, Vol. 4, p13 

    Background: A functional blood supply is essential for tumor growth and proliferation. However, the mechanism of blood vessel recruitment to the tumor is still poorly understood. Ideally, a thorough molecular assessment of blood vessel cells would be critical in our comprehension of this...

  • Can PPARγ Ligands Be Used in Cancer Therapy? Rumi, M. A.K.; Ishihara, S.; Kazumori, H.; Kadowaki, Y.; Kinoshita, Y. // Current Medicinal Chemistry - Anti-Cancer Agents;Nov2004, Vol. 4 Issue 6, p465 

    The role of peroxisome-proliferator activated receptor (PPAR)γ in tumor growth inhibition has been extensively studied during last seven years but still remains debated. Many in vitro and xenograft studies have demonstrated that PPARγ ligands are anti-tumorigenic due to anti-proliferative,...

  • A 3-D model of tumor progression based on complex automata driven by particle dynamics. Rafał Wcisło; Witold Dzwinel; David Yuen; Arkadiusz Dudek // Journal of Molecular Modeling;Dec2009, Vol. 15 Issue 12, p1517 

    Abstract  The dynamics of a growing tumor involving mechanical remodeling of healthy tissue and vasculature is neglected in most of the existing tumor models. This is due to the lack of efficient computational framework allowing for simulation of mechanical interactions. Meanwhile, just...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics